RBC raises target for HCA Healthcare stock to USD 496

Published on 10/12/2026 at 11:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 20.23 billion in the second quarter, up 8.70 percent. HCA Healthcare stock costs EUR 402.95 on October 12, 2026, with results October 27.

Key points in brief

RBC raised its HCA Healthcare price target from USD 435.00 to USD 496.00 on October 7, 2026.
Second-quarter 2026 revenue rose 8.70 percent to USD 20.23 billion, while diluted earnings per share reached USD 7.62.
HCA Healthcare stock was at EUR 402.95 at Lang & Schwarz on October 12, 2026 at 11:03 a.m. CEST.
HCA Healthcare is scheduled to report third-quarter 2026 results on October 27, 2026.

Farbiges Pop-Art-Comic mit Arzt und Krankenschwester als Helden vor Krankenhaus im 60er-Jahre-Stil — HCA Healthcare US40412C1018 Pop Art Comic mit heroischen Arzt und Pflegefiguren vor Krankenhaus im Retrostil, Illustration mit AI erstellt.

RBC Capital raised its HCA Healthcare price target from USD 435.00 to USD 496.00 on October 7, 2026, while maintaining an Outperform rating, as Markets Insider reported. The revision lifts the target by 14.02 percent from the earlier level and makes the upcoming earnings report the next major test for the thesis.

RBC raises the target

RBC's new USD 496.00 target compares with HCA Healthcare's EUR 402.95 Lang & Schwarz price on October 12, 2026, but the currencies are different and do not support a direct upside calculation. The research note described HCA as a near-term strategic pick ahead of third-quarter results, according to Markets Insider.

Three dates shape the story

On July 24, 2026, HCA reported USD 20.23 billion in second-quarter revenue and diluted earnings per share of USD 7.62, according to MarketBeat. Revenue increased 8.70 percent year over year, while net income attributable to common shareholders reached USD 1.699 billion for the quarter.

On September 30, 2026, HCA Healthcare announced that its third-quarter earnings call would take place on October 27, 2026, at 10:00 a.m. Eastern, according to the company's investor-relations release. RBC then published its target change on October 7, 2026, completing the latest sequence of dated developments.

What does the target change mean?

The key operating comparison remains the second-quarter revenue increase of 8.70 percent, paired with USD 7.62 in diluted earnings per share. That combination gives the October 27 report a clear measurement point: investors will be able to compare third-quarter revenue, earnings and management commentary with the USD 20.23 billion and USD 7.62 benchmarks from the second quarter.

Price holds the daily reference

HCA Healthcare stock was trading at EUR 402.95 at Lang & Schwarz on October 12, 2026 at 11:03 a.m. CEST. The company carries a USD 97.7 billion market capitalization and a USD 353.99 to USD 556.52 52-week range based on the October 9, 2026 primary-market snapshot.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.